関連する実験動画
Updated: Jul 17, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
S6K1欠乏マウスにおける低インスリン血症,グルコース不耐症,ベータ細胞サイズ減少
Nature
|January 5, 2001
まとめ
S6キナーゼ1が欠けていたマウスは,インスリン濃度が低下し,グルコース不耐性を示した. これは,インスリン抵抗性ではなく,2型糖尿病を模倣した,より小さな臓ベータ細胞によるものです.
科学分野:
- メタボリズムは
- エンドクリノロジー エンドクリノロジー
- 分子生物学は分子生物学である.
背景:
- インスリンは,インスリン受容体基板 (IRS-1,IRS-2) と異なるシグナル伝達経路を通じて,グルコースホメオスタシスを調節する.
- これらの経路を媒介するエフェクターと,グルコースの恒常性におけるその役割は,完全に理解されていません.
研究 の 目的:
- フォスファティディルノシチド-3-OHキナーゼ (PI3K) 経路エフェクターであるS6キナーゼ1 (S6K1) が,グルコースホメオスタシスとインスリン分泌における役割を調査する.
主な方法:
- S6キナーゼ1が欠乏したマウスを生成し,分析した.
- 評価されたグルコース耐性,インスリン濃度,インスリン分泌,および臓β細胞の質量およびサイズ.
主要な成果:
- S6キナーゼ1欠乏したマウスは,低インスリン血症とグルコース不耐性を示す.
- これらのマウスは,グルコース誘発インスリン分泌と臓インスリン含有量の低下を示しており,これは臓内分泌質量減少とベータ細胞のサイズ減少に関連しています.
- インスリン抵抗性は,孤立した筋肉組織では観察されなかった.
結論:
- S6キナーゼ1は,臓β細胞の質量と機能を維持する上で重要な役割を果たします.
- S6K1欠乏症は,臨床前の2型糖尿病に似たフェノタイプにつながり,グルコースホメオスタシスにおけるその重要性を強調しています.
関連する概念動画
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.